SUSUGUT: Effect of the Sustainable Diet on Gut Microbiota and the Metabolome: a Randomised Crossover Study

Sponsor
University of Ulster (Other)
Overall Status
Completed
CT.gov ID
NCT05231317
Collaborator
Fondazione Edmund Mach (Other)
20
1
2
5.5
3.6

Study Details

Study Description

Brief Summary

Unhealthy diets are closely linked to non-communicable diseases and constitute higher risk of morbidity and mortality than unsafe sex, alcohol, tobacco and drugs use combined. According to the World Health Organization (WHO), a healthy diet follows a plant-based pattern with low quantities of red meat and a low simple sugar intake. It would also reduce anthropological ecologic impact. We hypothesize that a plant-based diet will beneficially modify the gut microbiota and metabolome, influencing also Trimethylamine N-oxide (TMAO), a metabolite associated to CVD.

This study has a randomized single blind crossover design that compares a plant-based diet towards a control western diet. It is applied to volunteers aged 18-70 years, N=20. Each dietary intervention (plant-based and western) would last for 16 consecutive days separated by a minimum of 7 weeks washout period (intervention 1-washout-intervention 2). Samples of blood urine and faeces will be collected at day 1 and 14 of each intervention. On day 14 will be performed L-carnitine challenge with 1200mg of L-carnitine to test the levels of TMAO), in for the next 2 consecutive days (24h and 48h post treatment).

Condition or Disease Intervention/Treatment Phase
  • Other: Plant-based diet
  • Other: Western diet
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Cross-over single-blindedCross-over single-blinded
Masking:
Single (Participant)
Masking Description:
Single-blind
Primary Purpose:
Prevention
Official Title:
Effect of the Sustainable Diet on Gut Microbiota and the Metabolome: a Randomised Crossover Study
Actual Study Start Date :
Jul 2, 2021
Actual Primary Completion Date :
Dec 17, 2021
Actual Study Completion Date :
Dec 17, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental: Plant-based diet

Diet rich in fruit and vegetables (42% carbohydrates, 17.2% fibres; 15% proteins and 43% fats).

Other: Plant-based diet
16 days with all foods provided

Active Comparator: Active Comparator: Western diet

Diet Rich in Processed Foods (48% carbohydrates, 10.4% fibres; 14% proteins and 39% fats).

Other: Western diet
16 days with all foods provided

Outcome Measures

Primary Outcome Measures

  1. Gut microbiota changes [Change over 14 days]

    Significant changes in the number of bifidobacteria

  2. Quantification of Trimethylamine N-oxide [Day 16]

    Changes in response to L-Carnitine challenge

Secondary Outcome Measures

  1. Bioactivity of faecal water [Change over 14 days]

    Measured by using faecal water as basis for growth media (ex vivo measure)

  2. Effects on inflammatory markers of both diets [Change over 14 days]

    Cytokine analysis via ELISA test (MagPix)

  3. Ex vivo effects of faecal water on gut pathobionts [Day 14]

    Co-culturing the aqueous phase of faeces with C. difficile to assess changes in its biology

  4. Quantification of phytochemicals [Change over 14 days]

    Measured by LC-MS

  5. Quantification of Short Chain Fatty Acids (SCFA) [Change over 14 days]

    Measured by nuclear magnetic resonance (NMR)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Free-living, apparently healthy adults

  • Bmi>18

  • Aged 18-70 years at recruitment

  • Non-smokers

Exclusion criteria:
  • Non-free-living adults

  • Adults <18 or >70 years at recruitment

  • BMI<18

  • Current smokers

Contacts and Locations

Locations

Site City State Country Postal Code
1 Human Intervention Studies Unit, Ulster University Coleraine Londonderry United Kingdom BT52 1SA

Sponsors and Collaborators

  • University of Ulster
  • Fondazione Edmund Mach

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Ulster
ClinicalTrials.gov Identifier:
NCT05231317
Other Study ID Numbers:
  • REC/20/0008
First Posted:
Feb 9, 2022
Last Update Posted:
Feb 9, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Ulster

Study Results

No Results Posted as of Feb 9, 2022